Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Epigenetic Epidemiology of Obesity, Type 2 Diabetes, and Metabolic Disorders

  • Chapter
  • First Online:
Epigenetic Epidemiology

  • 2333 Accesses

Abstract

Knowledge and inclusion of epigenetic variants as potential risk factors for obesity and type 2 diabetes (T2D) will improve diagnosis and mechanistic understanding of these complex metabolic disorders. A number of practical and conceptual issues still have to be worked out before epidemiological studies can fully integrate epigenomic approaches. Altered patterns of histone modifications, DNA methylation, and microRNA levels are implicated in obesity and T2D. Recent studies are discussed, thereby illustrating strengths and challenges to accurately identify and measure epigenetic differences that covary with metabolic disorders. Unlike classical, DNA sequence-based approaches, the choice of cell or tissue type as source material may confound the results of such epigenomic studies. It is becoming clear that various types of epigenetic signatures exist; some are very stable and do not change over many years within an individual, whereas others are liable to change and perhaps more influenced by age and environmental and physiological conditions. A standardized classification system to accurately describe and characterize the properties of newly identified epigenetic signatures will enable the generation of reproducible epigenetic data.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AS:

Angelman syndrome

BMI:

Body mass index

CNV:

Copy number variation

DMR:

Differentially methylated region

GWAS:

Genome-wide association study

LOI:

Loss of imprinting

PBL:

Peripheral blood lymphocyte

PWS:

Prader-Willi syndrome

SNP:

Single nucleotide polymorphism

T2D:

Type 2 diabetes

VMR:

Variably methylated region

References

  1. Flintoft L (2010) Complex disease: adding epigenetics to the mix. Nat Rev Genet 11:94–95

    Article  Google Scholar 

  2. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE (1990) The body-mass index of twins who have been reared apart. N Engl J Med 322:1483–1487

    Article  PubMed  CAS  Google Scholar 

  3. Turula M, Kaprio J, Rissanen A, Koskenvuo M (1990) Body weight in the Finnish Twin Cohort. Diabetes Res Clin Pract 10(Suppl 1):S33–S36

    Article  PubMed  Google Scholar 

  4. Wardle J, Carnell S, Haworth CM, Plomin R (2008) Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr 87:398–404

    Google Scholar 

  5. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579–589

    Article  PubMed  CAS  Google Scholar 

  6. Consortium WTCC (2010) Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464:713–720

    Article  Google Scholar 

  7. Stöger R (2008) The thrifty epigenotype: an acquired and heritable predisposition for obesity and diabetes? Bioessays 30:156–166

    Article  PubMed  Google Scholar 

  8. Stöger R (2008) Epigenetics and obesity. Pharmacogenomics 9:1851–1860

    Article  PubMed  Google Scholar 

  9. Koza RA, Nikonova L, Hogan J, Rim JS, Mendoza T, Faulk C et al (2006) Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet 2:e81

    Article  PubMed  Google Scholar 

  10. Chen Y, Zhu J, Lum PY, Yang X, Pinto S, MacNeil DJ et al (2008) Variations in DNA elucidate molecular networks that cause disease. Nature 452:429–435

    Article  PubMed  CAS  Google Scholar 

  11. Ling C, Groop L (2009) Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 58:2718–2725

    Article  PubMed  CAS  Google Scholar 

  12. Rönn T, Poulsen P, Hansson O, Holmkvist J, Almgren P, Nilsson P et al (2008) Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia 51:1159–1168

    Article  PubMed  Google Scholar 

  13. Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS (2002) Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51:1913–1920

    Article  PubMed  CAS  Google Scholar 

  14. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J et al (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267–273

    Article  PubMed  CAS  Google Scholar 

  15. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S et al (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100:8466–8471

    Article  PubMed  CAS  Google Scholar 

  16. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML et al (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102:10604–10609

    Article  PubMed  CAS  Google Scholar 

  17. Rhodes CJ (2005) Type 2 diabetes-a matter of beta-cell life and death? Science 307:380–384

    Article  PubMed  CAS  Google Scholar 

  18. Gaulton KJ, Nammo T, Pasquali L, Simon JM, Giresi PG, Fogarty MP et al (2010) A map of open chromatin in human pancreatic islets. Nat Genet 42:255–259

    Article  PubMed  CAS  Google Scholar 

  19. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P et al (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117:2155–2163

    Article  PubMed  CAS  Google Scholar 

  20. Lee SH, Demeterco C, Geron I, Abrahamsson A, Levine F, Itkin-Ansari P (2008) Islet specific Wnt activation in human type II diabetes. Exp Diabetes Res 2008:728763

    PubMed  Google Scholar 

  21. Ingelsson E, Langenberg C, Hivert MF, Prokopenko I, Lyssenko V, Dupuis J et al (2010) Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes 59:1266–1275

    Article  PubMed  CAS  Google Scholar 

  22. Liu Z, Habener JF (2010) Wnt signaling in pancreatic islets. Adv Exp Med Biol 654:391–419

    Article  PubMed  CAS  Google Scholar 

  23. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB et al (2011) Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473:43–49

    Article  PubMed  CAS  Google Scholar 

  24. Richards EJ (2006) Inherited epigenetic variation–revisiting soft inheritance. Nat Rev Genet 7:395–401

    Article  PubMed  CAS  Google Scholar 

  25. Richards EJ (2008) Population epigenetics. Curr Opin Genet Dev 18:221–226

    Article  PubMed  CAS  Google Scholar 

  26. Bhandare R, Schug J, Le Lay J, Fox A, Smirnova O, Liu C et al (2010) Genome-wide analysis of histone modifications in human pancreatic islets. Genome Res 20:428–433

    Article  PubMed  CAS  Google Scholar 

  27. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129:823–837

    Article  PubMed  CAS  Google Scholar 

  28. Mutskov V, Felsenfeld G (2009) The human insulin gene is part of a large open chromatin domain specific for human islets. Proc Natl Acad Sci USA 106:17419–17424

    Article  PubMed  CAS  Google Scholar 

  29. Melkman-Zehavi T, Oren R, Kredo-Russo S, Shapira T, Mandelbaum AD, Rivkin N, Nir T, Lennox KA, Behlke MA, Dor Y, Hornstein E (2011) miRNAs control insulin content in pancreatic beta-cells via downregulation of transcriptional repressors. EMBO J 30:835–845

    Article  PubMed  CAS  Google Scholar 

  30. Schwartz MW, Porte D Jr (2005) Diabetes, obesity, and the brain. Science 307:375–379

    Article  PubMed  CAS  Google Scholar 

  31. Simpson KA, Martin NM, Bloom SR (2008) Hypothalamic regulation of appetite. Expert Rev Endocrinol Metab 3:577–592

    Article  CAS  Google Scholar 

  32. Vucetic Z, Reyes MT (2010) Central dopaminergic circuitry controlling food intake and reward: implications for the regulation of obesity. Wiley Interdiscip Rev Syst Biol Med 2:577–593

    PubMed  CAS  Google Scholar 

  33. Bellet MM, Sassone-Corsi P (2010) Mammalian circadian clock and metabolism – the epigenetic link. J Cell Sci 123:3837–3848

    Article  PubMed  CAS  Google Scholar 

  34. McConkie-Rosell A, Lachiewicz AM, Spiridigliozzi GA, Tarleton J, Schoenwald S, Phelan MC et al (1993) Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. Am J Hum Genet 53:800–809

    PubMed  CAS  Google Scholar 

  35. Stöger R, Kajimura TM, Brown WT, Laird CD (1997) Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum Mol Genet 6:1791–1801

    Article  PubMed  Google Scholar 

  36. Terracciano A, Chiurazzi P, Neri G (2005) Fragile X syndrome. Am J Med Genet C Semin Med Genet 137C:32–37

    Article  PubMed  Google Scholar 

  37. Laird CD (1987) Proposed mechanism of inheritance and expression of the human fragile-X syndrome of mental retardation. Genetics 117:587–599

    PubMed  CAS  Google Scholar 

  38. Willemsen R, Bontekoe CJ, Severijnen LA, Oostra BA (2002) Timing of the absence of FMR1 expression in full mutation chorionic villi. Hum Genet 110:601–605

    Article  PubMed  CAS  Google Scholar 

  39. Waterland RA, Garza C (1999) Potential mechanisms of metabolic imprinting that lead to chronic disease. Am J Clin Nutr 69:179–197

    PubMed  CAS  Google Scholar 

  40. Hales CN, Ozanne SE (2003) For debate: Fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. Diabetologia 46:1013–1019

    Article  PubMed  CAS  Google Scholar 

  41. Simmons R (2005) Developmental origins of adult metabolic disease: concepts and controversies. Trends Endocrinol Metab 16:390–394

    Article  PubMed  CAS  Google Scholar 

  42. Gallou-Kabani C, Junien C (2005) Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic. Diabetes 54:1899–1906

    Article  PubMed  CAS  Google Scholar 

  43. Holness MJ, Sugden MC (2006) Epigenetic regulation of metabolism in children born small for gestational age. Curr Opin Clin Nutr Metab Care 9:482–488

    Article  PubMed  CAS  Google Scholar 

  44. Stein Z (1975) Famine and human development: the Dutch hunger winter of 1944–1945. Oxford University Press, New York

    Google Scholar 

  45. Stein AD, Kahn HS, Rundle A, Zybert PA, van der Pal-de BK, Lumey LH (2007) Anthropometric measures in middle age after exposure to famine during gestation: evidence from the Dutch famine. Am J Clin Nutr 85:869–876

    PubMed  CAS  Google Scholar 

  46. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES et al (2008) Persistent ­epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 105:17046–17049

    Article  PubMed  CAS  Google Scholar 

  47. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD et al (2009) DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet 18:4046–4053

    Article  PubMed  CAS  Google Scholar 

  48. Wellen KE, Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785–1788

    PubMed  CAS  Google Scholar 

  49. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821–1830

    PubMed  CAS  Google Scholar 

  50. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808

    PubMed  CAS  Google Scholar 

  51. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M et al (2008) T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28:1304–1310

    Article  PubMed  CAS  Google Scholar 

  52. Stöger R (2006) In vivo methylation patterns of the Leptin promoter in human and mouse. Epigenetics 1:155–162

    Article  PubMed  Google Scholar 

  53. Noer A, Sorensen AL, Boquest AC, Collas P (2006) Stable CpG hypomethylation of adipogenic promoters in freshly isolated, cultured, and differentiated mesenchymal stem cells from adipose tissue. Mol Biol Cell 17:3543–3556

    Article  PubMed  Google Scholar 

  54. El-Maarri O, Becker T, Junen J, Manzoor SS, Diaz-Lacava A, Schwaab R et al (2007) Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum Genet 122:505–514

    Article  PubMed  CAS  Google Scholar 

  55. Feinberg AP, Irizarry RA, Fradin D, Aryee MJ, Murakami P, Aspelund T et al (2010) Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci Transl Med 2:49–67

    Article  Google Scholar 

  56. Irizarry RA, Ladd-Acosta C, Carvalho B, Wu H, Brandenburg SA, Jeddeloh JA et al (2008) Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res 18:780–790

    Article  PubMed  CAS  Google Scholar 

  57. Harris TB, Launer LJ, Eiriksdottir G, Kjartansson O, Jonsson PV, Sigurdsson G et al (2007) Age, gene/environment susceptibility-Reykjavik study: multidisciplinary applied phenomics. Am J Epidemiol 165:1076–1087

    Article  PubMed  Google Scholar 

  58. Nair S, Lee YH, Rousseau E, Cam M, Tataranni PA, Baier LJ et al (2005) Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia 48:1784–1788

    Article  PubMed  CAS  Google Scholar 

  59. O’Hara A, Lim FL, Mazzatti DJ, Trayhurn P (2009) Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned medium. Pflugers Arch 458:1103–1114

    Article  PubMed  Google Scholar 

  60. Cardellini M, Menghini R, Martelli E, Casagrande V, Marino A, Rizza S et al (2009) TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 58:2396–2401

    Article  PubMed  CAS  Google Scholar 

  61. Kent CF, Daskalchuk T, Cook L, Sokolowski MB, Greenspan RJ (2009) The Drosophila foraging gene mediates adult plasticity and gene-environment interactions in behaviour, metabolites, and gene expression in response to food deprivation. PLoS Genet 5:e1000609

    Article  PubMed  Google Scholar 

  62. Zakharkin SO, Belay AT, Fernandez JR, De Luca V, Kennedy JL, Sokolowski MB et al (2005) Lack of association between polymorphism of the human cyclic GMP-dependent protein kinase gene and obesity. Int J Obes (Lond) 29:872–874

    Article  CAS  Google Scholar 

  63. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA et al (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms’ tumour. Nature 362:749–751

    Article  PubMed  CAS  Google Scholar 

  64. Feinberg AP (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447:433–440

    Article  PubMed  CAS  Google Scholar 

  65. Constancia M, Kelsey G, Reik W (2004) Resourceful imprinting. Nature 432:53–57

    Article  PubMed  CAS  Google Scholar 

  66. Charalambous M, da Rocha ST, Ferguson-Smith AC (2007) Genomic imprinting, growth control and the allocation of nutritional resources: consequences for postnatal life. Curr Opin Endocrinol Diabetes Obes 14:3–12

    Article  PubMed  CAS  Google Scholar 

  67. Moore T, Haig D (1991) Genomic imprinting in mammalian development: a parental tug-of-war. Trends Genet 7:45–49

    PubMed  CAS  Google Scholar 

  68. Haig D (2000) The kinship theory of genomic imprinting. Annu Rev Ecol Syst 31:9–32

    Article  Google Scholar 

  69. Haig D (2004) Genomic imprinting and kinship: how good is the evidence? Annu Rev Genet 38:553–585

    Article  PubMed  CAS  Google Scholar 

  70. Parker-Katiraee L, Carson AR, Yamada T, Arnaud P, Feil R, Abu-Amero SN, Moore GE, Kaneda M, Perry GH, Stone AC, Lee C, Meguro-Horike M et al (2007) Identification of the imprinted KLF14 transcription factor undergoing human-specific accelerated evolution. PLoS Genet 3:e65

    Article  PubMed  CAS  Google Scholar 

  71. Small KS, Hedman AK, Grundberg E, Nica AC, Thorleifsson G, Kong A, Thorsteindottir U, Shin SY, Richards HB, Soranzo N, Ahmadi KR, Lindgren CM et al (2011) Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat Genet 43:561–564

    Article  PubMed  CAS  Google Scholar 

  72. Shapira NA, Lessig MC, He AG, James GA, Driscoll DJ, Liu Y (2005) Satiety dysfunction in Prader-Willi syndrome demonstrated by fMRI. J Neurol Neurosurg Psychiatry 76:260–262

    Article  PubMed  CAS  Google Scholar 

  73. Herzing LB, Kim SJ, Cook EH Jr, Ledbetter DH (2001) The human aminophospholipid-transporting ATPase gene ATP10C maps adjacent to UBE3A and exhibits similar imprinted expression. Am J Hum Genet 68:1501–1505

    Article  PubMed  CAS  Google Scholar 

  74. Hogart A, Patzel KA, LaSalle JM (2008) Gender influences monoallelic expression of ATP10A in human brain. Hum Genet 124:235–242

    Article  PubMed  CAS  Google Scholar 

  75. Kelsey G (2009) Epigenetics and imprinted genes: insights from the imprinted Gnas locus. Horm Res 71(Suppl 2):22–29

    Article  PubMed  CAS  Google Scholar 

  76. Weinstein LS, Xie T, Qasem A, Wang J, Chen M (2010) The role of GNAS and other imprinted genes in the development of obesity. Int J Obes (Lond) 34:6–17

    Article  CAS  Google Scholar 

  77. Kassem SA, Ariel I, Thornton PS, Hussain K, Smith V, Lindley KJ et al (2001) p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 50:2763–2769

    Article  PubMed  CAS  Google Scholar 

  78. Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H et al (2008) Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 40:1092–1097

    Article  PubMed  CAS  Google Scholar 

  79. Kong A, Steinthorsdottir V, Masson G, Thorleifsson G, Sulem P, Besenbacher S et al (2009) Parental origin of sequence variants associated with complex diseases. Nature 462:868–874

    Article  PubMed  CAS  Google Scholar 

  80. Sakatani T, Wei M, Katoh M, Okita C, Wada D, Mitsuya K et al (2001) Epigenetic heterogeneity at imprinted loci in normal populations. Biochem Biophys Res Commun 283:1124–1130

    Article  PubMed  CAS  Google Scholar 

  81. Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP (2002) Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 62:6442–6446

    PubMed  CAS  Google Scholar 

  82. Petrik J, Pell JM, Arany E, McDonald TJ, Dean WL, Reik W et al (1999) Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 140:2353–2363

    Article  PubMed  CAS  Google Scholar 

  83. Milo-Landesman D, Efrat S (2002) Growth factor-dependent proliferation of the pancreatic beta-cell line betaTC-tet: an assay for beta-cell mitogenic factors. Int J Exp Diabetes Res 3:69–74

    Article  PubMed  Google Scholar 

  84. Devedjian JC, George M, Casellas A, Pujol A, Visa J, Pelegrin M et al (2000) Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. J Clin Invest 105:731–740

    Article  PubMed  CAS  Google Scholar 

  85. Bouwens L, Rooman I (2005) Regulation of pancreatic beta-cell mass. Physiol Rev 85:1255–1270

    Article  PubMed  CAS  Google Scholar 

  86. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, Heim MH, Stoffel M (2011) MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474:649–653

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

I am grateful to the editor, Karin Michels, as well as Catherine Suter and David Martin for comments and suggestions on the manuscript.

Author information

Authors and Affiliations

  1. School of Biosciences, University of Nottingham, Nottingham, UK

    Reinhard Stöger

Authors
  1. Reinhard Stöger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reinhard Stöger .

Editor information

Editors and Affiliations

  1. , Obstetrics and Gynecology Epidemiology D, Brigham and Women’s Hospital, Longwood Avenue 221, Boston, 02115, Massachusetts, USA

    Karin B. Michels

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Stöger, R. (2012). Epigenetic Epidemiology of Obesity, Type 2 Diabetes, and Metabolic Disorders. In: Michels, K. (eds) Epigenetic Epidemiology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2495-2_20

Download citation

Publish with us

Policies and ethics

Search

Navigation